 lack of evidence for
efÔ¨Åcacy.90 In a UK-based cost analysis,91 accounting for
clinical recurrences and need for further treatment,
analysis included cost of procedure and subsequent
procedures and quality-adjusted life-years. Across all
measures, compression therapy was found to be inferior
to minimally invasive endovenous therapies (including
ultrasound-guided
FS
[UGFS]
and
endovenous

thermal ablation).91 Although the